Abstract
We report that in vivo injection of endotoxin (EDTX, 6 mg. kg(-)(1)) induces cardiovascular alterations in rats that closely mimic the clinical situation, as assessed by in vivo hemodynamic measurements in anesthetized and conscious, chronically instrumented animals. The patch-clamp technique was used to characterize the L-type calcium current (I(Ca)) and its autonomic regulation in isolated cardiac myocytes. The density of I(Ca) progressively decreased at 12 and 36 h after EDTX injection. However, the dihydropyridine (+/-)Bay K 8644 (100 nM) enhanced I(Ca) to levels similar to those in control and EDTX-treated myocytes. In addition, the net stimulatory effect of a beta-adrenergic agonist (isoproterenol) on I(Ca) was increased 12 h after EDTX injection. This change in the beta-adrenergic effect declined 24 h later. The potentiation in the beta-adrenergic stimulation of I(Ca) was mimicked by L858051 (10 microM), a direct activator of adenylyl cyclase, but not by IBMX (200 microM), a phosphodiesterase inhibitor. Besides, the antiadrenergic effect of acetylcholine on I(Ca) was unchanged 12 h after EDTX injection, but increased 36 h after EDTX injection. These results support the hypothesis that time-dependent changes in the adenylyl cyclase pathway in cardiac myocytes may contribute, via the autonomic regulation of I(Ca), to the severity of myocardial dysfunction during sepsis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Methyl-3-isobutylxanthine / pharmacology
-
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
-
Acetylcholine / pharmacology
-
Acetylcholine / physiology
-
Adenylyl Cyclases / metabolism
-
Adrenergic Antagonists / pharmacology
-
Adrenergic beta-Agonists / pharmacology
-
Animals
-
Autonomic Nervous System / physiology*
-
Calcium Channel Agonists / pharmacology
-
Calcium Channels, L-Type / metabolism
-
Colforsin / analogs & derivatives
-
Colforsin / pharmacology
-
Diterpenes
-
Electrophysiology
-
Endotoxemia / physiopathology
-
Endotoxins / administration & dosage
-
Endotoxins / pharmacology*
-
Enzyme Activators / pharmacology
-
Escherichia coli
-
Heart / innervation*
-
Heart / physiology
-
Hemodynamics
-
In Vitro Techniques
-
Injections, Intravenous
-
Isoproterenol / pharmacology
-
Male
-
Myocardium / cytology*
-
Myocardium / metabolism
-
Patch-Clamp Techniques
-
Phosphodiesterase Inhibitors / pharmacology
-
Rats
-
Sepsis / physiopathology
Substances
-
Adrenergic Antagonists
-
Adrenergic beta-Agonists
-
Calcium Channel Agonists
-
Calcium Channels, L-Type
-
Diterpenes
-
Endotoxins
-
Enzyme Activators
-
Phosphodiesterase Inhibitors
-
L 858051
-
Colforsin
-
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
-
Adenylyl Cyclases
-
Isoproterenol
-
Acetylcholine
-
1-Methyl-3-isobutylxanthine